Vicriviroc malate

Overview

Vicriviroc (SCH 417690) malate is an orally active CCR5 antagonist with the IC 50 of 10 nM, and also inhibts MIP-1α and intracellular calcium release induced by the ligand RANTES (10 nM) with the IC 50 values of 0.91 nM and 16 nM,,respectively. Vicriviroc malate can inhibits human immunodeficiency virus type 1 ( HIV-1 ) infection , and can also used for study of cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Infection | Products > Signaling Pathways > CCR | Products > Signaling Pathways > HIV

Product Information

• Catalog No.: HY-B0155B
• CAS No.: 541503-81-5
• Molecular Formula: C32H44F3N5O7
• Molecular Weight: 667.72
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source